SLM Student Loan Trust 2011-2 $821 Million Notes Assigned Ratings May 11

  • ID: 1806601
  • May 2011
  • Standard & Poors
1 of 3

OVERVIEW SLM Student Loan Trust 2011-2's note issuance is a pool of consolidation student loans originated under the Federal Family Education Loan Program (the loans are at least 97% federally reinsured). We assigned our ratings to the class A and B notes. The ratings reflect our view of the transaction's total and senior parities, U.S. federal government reinsurance of 97% of the pool's principal and interest, and timely interest and principal payments, as well as our stress scenarios, among other factors. NEW YORK (Standard & Poor's) May 26, 2011--Standard & Poor's Ratings Services today assigned its ratings to SLM Student Loan Trust 2011-2's $821 million class A and B student loan-backed notes (see list). The ratings reflect our assessment of:...

Companies mentioned in this report are: SLM Student Loan Trust 2011-2
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

SLM Student Loan Trust 2011-2

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.